MedTrace Logo

Nasal Tea Tree Oil for the Prevention of Infections in PD Patients

NCT01214395 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2012-08-03

Study results available
· View outcomes & findings →

Summary

This study will compare the use of tea tree oil as a topical nasal antiseptic to prevent infections in patients that need renal dialysis. A maximum of fifty subjects will be recruited and will be assessed for signs of infection once per week for the first 6 weeks and then every 4 weeks until week 26. They will also be checked for nasal carriage of 'Golden Staph' when they enroll in the trial. The subjects will complete the trial if they have 26 weeks infection-free or if they have an infection during that period

Conditions

  • End Stage Renal Failure on Dialysis

Interventions

DRUG

5% tea tree oil nasal ointment

daily for 5 days then weekly for 6 months

Sponsors & Collaborators

  • PathWest Laboratory Medicine WA

    lead OTHER_GOV

Principal Investigators

  • Brian Hutchison, MBBS · Sir Charles Gairdner Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01214395 on ClinicalTrials.gov